Přihlásit se Zaregistrujte se zdarma

Beta společnosti Theratechnologies

Jaká je hodnota metriky Beta společnosti Theratechnologies?

Hodnota metriky Beta společnosti Theratechnologies, Inc. je 1.38

Jaká je definice metriky Beta?



BETA koeficient vyjadřuje, zda je akcie více či méně volatilní než trh jako celek. Beta menší než 1 znamená, že akcie jsou méně volatilní než trh, zatímco beta větší než 1 znamená, že akcie jsou volatilnější. Volatilita se měří pomocí fluktuace ceny akcie.

Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.

Beta společností v sektoru Health Care sektor na TSX ve srovnání se společností Theratechnologies

Čemu se věnuje společnost Theratechnologies?

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

Firmy s metrikou beta podobnou společnosti Theratechnologies



  • Hodnota metriky Beta společnosti AXA SA je 1.38
  • Hodnota metriky Beta společnosti AXA SA je 1.38
  • Hodnota metriky Beta společnosti Freshii je 1.38
  • Hodnota metriky Beta společnosti Zai Lab je 1.38
  • Hodnota metriky Beta společnosti IFCI je 1.38
  • Hodnota metriky Beta společnosti IFCI je 1.38
  • Hodnota metriky Beta společnosti Theratechnologies je 1.38
  • Hodnota metriky Beta společnosti Beowulf Mining plc je 1.38
  • Hodnota metriky Beta společnosti Systemair AB (publ) je 1.38
  • Hodnota metriky Beta společnosti engage:BDR je 1.38
  • Hodnota metriky Beta společnosti Adtran je 1.38
  • Hodnota metriky Beta společnosti Abercrombie & Fitch Co je 1.38
  • Hodnota metriky Beta společnosti TruFin plc je 1.38